UPDATE 1-Roche in $550 mln deal for superbug-fighting antibiotic

Swiss drugmaker Roche will pay up to 500 million Swiss francs for an experimental antibiotic, marking a rare foray by a major pharmaceutical firm into the battle against so-called "superbug" infections found in hospitals.

http://www.reuters.com/article/2013/11/04/roche-polyphor-idUSL5N0IP0LF20131104?feedType=RSS&feedName=rbssHealthcareNews